MACROGENICS, INC. Shares Outstanding (Cover Page)
MACROGENICS, INC. (MGNX) had Shares Outstanding (Cover Page) of 63.70 million shares as of 2026-08-08, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-08: Entity Common Stock, Shares Outstanding 63.70M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 63.56M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 63.56M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 63.26M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-08 | 63.70M shares 10-Q · filed 2026-08-14 |
| 2026-05-08 | 63.56M shares 10-Q · filed 2026-05-13 |
| 2026-03-05 | 63.56M shares 10-K · filed 2026-03-09 |
| 2025-11-07 | 63.26M shares 10-Q · filed 2025-11-12 |
| 2025-08-08 | 63.21M shares 10-Q · filed 2025-08-14 |
| 2025-05-09 | 63.09M shares 10-Q · filed 2025-05-13 |
| 2025-03-14 | 63.09M shares 10-K · filed 2025-03-20 |
| 2024-11-01 | 62.76M shares 10-Q · filed 2024-11-05 |
| 2024-08-02 | 62.72M shares 10-Q · filed 2024-08-06 |
| 2024-05-03 | 62.63M shares 10-Q · filed 2024-05-09 |
| 2024-03-01 | 62.43M shares 10-K · filed 2024-03-07 |
| 2023-11-03 | 62.03M shares 10-Q · filed 2023-11-06 |
| 2023-08-04 | 61.95M shares 10-Q · filed 2023-08-09 |
| 2023-05-05 | 61.84M shares 10-Q · filed 2023-05-09 |
| 2023-02-28 | 61.84M shares 10-K · filed 2023-03-15 |
| 2022-10-31 | 61.48M shares 10-Q · filed 2022-11-03 |
| 2022-08-03 | 61.46M shares 10-Q · filed 2022-08-08 |
| 2022-04-29 | 61.33M shares 10-Q · filed 2022-05-03 |
| 2022-02-22 | 61.32M shares 10-K · filed 2022-02-24 |
| 2021-10-29 | 61.26M shares 10-Q · filed 2021-11-02 |
| 2021-07-26 | 61.11M shares 10-Q · filed 2021-07-29 |
| 2021-04-26 | 60.04M shares 10-Q · filed 2021-04-29 |
| 2021-02-22 | 56.26M shares 10-K · filed 2021-02-25 |
| 2020-10-30 | 56.20M shares 10-Q · filed 2020-11-04 |
| 2020-07-24 | 54.12M shares 10-Q · filed 2020-07-31 |
| 2020-05-01 | 49.14M shares 10-Q · filed 2020-05-05 |
| 2020-02-21 | 48.98M shares 10-K/A · filed 2020-03-02 |
| 2019-11-01 | 48.92M shares 10-Q · filed 2019-11-06 |
| 2019-07-26 | 48.89M shares 10-Q · filed 2019-07-31 |
| 2019-04-26 | 48.81M shares 10-Q · filed 2019-05-01 |
| 2019-02-22 | 48.78M shares 10-K · filed 2019-02-26 |
| 2018-11-02 | 42.26M shares 10-Q · filed 2018-11-07 |
| 2018-08-03 | 42.24M shares 10-Q · filed 2018-08-07 |
| 2018-05-04 | 42.20M shares 10-Q · filed 2018-05-07 |
| 2018-02-23 | 36.92M shares 10-K · filed 2018-02-27 |
| 2017-11-03 | 36.82M shares 10-Q · filed 2017-11-08 |
| 2017-07-31 | 36.80M shares 10-Q · filed 2017-08-02 |
| 2017-04-28 | 35.01M shares 10-Q · filed 2017-05-03 |
| 2017-02-24 | 34.97M shares 10-K · filed 2017-02-28 |
| 2016-10-31 | 34.84M shares 10-Q · filed 2016-11-02 |
| 2016-07-29 | 34.73M shares 10-Q · filed 2016-08-03 |
| 2016-04-29 | 34.55M shares 10-Q · filed 2016-05-04 |
| 2016-02-22 | 34.53M shares 10-K · filed 2016-02-29 |
| 2015-10-30 | 34.31M shares 10-Q · filed 2015-11-04 |
| 2015-07-31 | 34.20M shares 10-Q · filed 2015-08-05 |
| 2015-04-30 | 30.05M shares 10-Q · filed 2015-05-06 |
| 2015-02-27 | 29.97M shares 10-K · filed 2015-03-03 |
| 2014-10-31 | 27.79M shares 10-Q · filed 2014-11-12 |
| 2014-07-31 | 27.74M shares 10-Q · filed 2014-08-05 |
| 2014-04-30 | 27.62M shares 10-Q · filed 2014-05-06 |
| 2014-02-28 | 27.47M shares 10-K · filed 2014-03-20 |
| 2013-10-31 | 25.02M shares 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |